Your browser doesn't support javascript.
loading
Exploring the role and clinical implications of proteasome inhibition in medulloblastoma.
Hoerig, Clay M; Plant-Fox, Ashley S; Pulley, Michelle D; Di, Kaijun; Bota, Daniela A.
Affiliation
  • Hoerig CM; Department of Pediatric Hematology/Oncology, Children's Hospital Orange County, Orange, California, USA.
  • Plant-Fox AS; University of California, Irvine, California, USA.
  • Pulley MD; Department of Pediatric Oncology, Ann and Robert H. Lurie Children's Hospital Chicago, Illinois, USA.
  • Di K; University of California, Irvine, California, USA.
  • Bota DA; Department of Pediatric Hematology/Oncology, Children's Hospital Orange County, Orange, California, USA.
Pediatr Blood Cancer ; 68(10): e29168, 2021 10.
Article in En | MEDLINE | ID: mdl-34114315
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cerebellar Neoplasms / Proteasome Inhibitors / Medulloblastoma Limits: Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2021 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cerebellar Neoplasms / Proteasome Inhibitors / Medulloblastoma Limits: Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2021 Document type: Article Affiliation country: Estados Unidos